EventsShow event


30th of November 2017
Cerenion Oy is one of only 20 companies invited to present to a group of international investors at the Life Science and Health Investor Lunch, taking place on November 30th 2017 in Helsinki, Finland.
The event organized by Tech Tour, Health Capital Helsinki, Finpro and Tekes in collaboration with Slush will take place at Messukeskus as a side event of SLUSH 2017. The lunch will bring together highly promising preselected life science and health startups with international investors focusing on biotech, pharma, diagnostics, personalized medicine, remote monitoring and diagnosis, as well as other life science sectors.
Cerenion Oy will be represented by Dr. Timo Koskela, CEO and Co-founder, at the event. If you would like to arrange a meeting with us at the event please contact Timo directly.

Meet us there

Timo Koskela, PhD (Eng.), MSc (Econ.&Bus.Adm)
Chief Executive Officer, Co-founder

Would you like to know more?

We would be happy to tell you more about our technology, and talk about possible avenues of collaboration. So please don't hesitate to contact us for more information.

Contact us

Dr. Timo Koskela, CEO
tel. +358 40 5773 706

Visit us

Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Teknobulevardi 3-5
01530 Vantaa
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Under no circumstances shall the information on this website be construed as an advertisement of any commercially available product. Cerenion™, Cerenion C-Trend™, C-Trend™, ''The next-generation brain monitoring company''™ and ''The pulse of the brain''™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2017.